www.leagle.com/decision/1995235234Conn1_1235/TOROSYAN v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
ANUSHAVAN G. TOROSYAN v. BOEHRINGER INGELHEIM
PHARMACEUTICALS, INC. PETERS, C. J. The principal issue in this appeal is
whether there was ...
Boehringer Ingelheim International GmbH has agreed to pay roughly $650
million to settle claims in multidistrict ... Richard W Cohen, Lowey Dannenberg et
Mar 26, 2014 ... First, Barre et al. reviewed that the STAT3 oncogenic pathway was associated
with .... Chugai Pharmaceutical Company and Boehringer-Ingelheim in Japan. ....
Catlett-Falcone R., Landowski T.H., Oshiro M.M., Turkson J., Levitzki A., ..... Politi
K., Sarkaria I., Singh B., Heelan R., Rusch V., Fulton L., et al.
Chemical Company, Gumi-City, Kyungbuk, Republic of Korea; 7Depart- ment of
Pharmacology ... AstraZeneca, Boehringer Ingelheim Pharma, and Pfizer,
respectively. AG490 ... Kim et al. Mol Cancer Ther; 11(10) October 2012.
Molecular Cancer Therapeutics. OF2 ... in 0.5% (w/v) methylcellulose containing
0.4% Tween 80.
Dec 13, 2001 ... ... the delay in NF-κB activation found in TRAF2-deficient mice by Mak et al. .....
800 μF and 250 V. Selection of transfectants commenced no sooner than 12 h ...
was purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). .....
Hostager, B. S., Catlett, I. M. and Bishop, G. A., Recruitment of CD40 and ...
Oct 17, 2013 ... Stanislas Pol: Consultant for Bristol-Myers Squibb, Boehringer Ingelheim,
Janssen, Vertex ... The REALIZE trial was funded by Janssen Pharmaceuticals
and Vertex ... In a study by Romero-Gomez et al., the effect of IR on SVR was
... Plasma HCV RNA was measured using the COBAS TaqMan assay, v.
Sciences, Inc., Merck & Co., Three Rivers Pharmaceuticals, LLC, and Vertex
Pharmaceuticals, Inc. Continuing Medical ... He received grants from Gilead,
Boehringer Ingelheim, Siemens, and Anadys. He holds ... Pineda et al. reported a
5-year incidence ..... V. Noncirrhotic portal hypertension in HIV-infected patients:
Financial support by AstraZeneca, Bayer Schering Pharma, Boehringer
Ingelheim, ..... Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E,
Wagenvoord R et al ..... Taylor FB, Chang A, Ruf W, Morrissey JH, Hinshaw L,
Catlett R et al. ..... trypsin inhibitor (CTI; Haematologic Technologies Inc, Essex
Junction, VT, USA), a.
Jan 3, 2012 ... Pharmaceutical Research & Manufacturers of America. Client or Employer ....
Boehringer Ingelheim Pharmaceuticals, Inc. Client or ..... c/o Nielsen Merksamer,
et al. 2350 Kerner ..... Catlett Law Firm, PLC ..... Donald V Allen.
Jul 1, 1986 ... 1987, ch. 37, par. 439.1 et seq. The Court of Claims has exclusive jurisdiction to
hear and determine the following matters: (a) all claims against ...